5
Participants
Start Date
October 31, 2007
Primary Completion Date
August 31, 2009
Study Completion Date
January 31, 2010
Eszopiclone
Subject receives Eszopiclone for 3 consecutive nights. 3 mg orally at bedtime for patients age 64 and under, and 2 mg QHS for patients age 65 and older.
Placebo
Subjects are given placebo for 3 consecutive nights
Southern Arizona VA Health Care System, Tucson
Sumitomo Pharma America, Inc.
INDUSTRY
Southern Arizona VA Health Care System
FED
University of Arizona
OTHER